|
1
|
Liu Q and Yang J: Expression and
significance of miR155 and vascular endothelial growth factor in
placenta of rats with preeclampsia. Int J Clin Exp Med.
8:15731–15737. 2015.PubMed/NCBI
|
|
2
|
ACOG Committee on Obstetric Practice: ACOG
practice bulletin. Diagnosis and management of preeclampsia and
eclampsia Number 33, January 2002 American College of Obstetricians
and Gynecologists. Int J Gynaecol Obstet. 77:67–75. 2002.
|
|
3
|
Solomon CG and Seely EW: Preeclampsia -
searching for the cause. N Engl J Med. 350:641–642. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Merviel P, Carbillon L, Challier JC,
Rabreau M, Beaufils M and Uzan S: Pathophysiology of preeclampsia:
Links with implantation disorders. Eur J Obstet Gynecol Reprod
Biol. 115:134–147. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang YY, Zhou R, Zhou B, Wang T, Zhang L
and Luo D: Overexpression of heparanase is associated with
preeclampsia by inhibiting invasion of trophocytes. Int J Clin Exp
Med. 8:18107–18114. 2015.
|
|
6
|
Stella P, Manunta P, Mallamaci F, Melandri
M, Spotti D, Tripepi G, Hamlyn JM, Malatino LS, Bianchi G and
Zoccali C: Endogenous ouabain and cardiomyopathy in dialysis
patients. J Intern Med. 263:274–280. 2008. View Article : Google Scholar
|
|
7
|
Takahashi H, Yoshika M, Komiyama Y and
Nishimura M: The central mechanism underlying hypertension: A
review of the roles of sodium ions, epithelial sodium channels, the
renin-angiotensin-aldosterone system, oxidative stress and
endogenous digitalis in the brain. Hypertens Res. 34:1147–1160.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lv ZR, Sha HJ and Hamillon BP: The
experimental investigation on the biosynthetic pathway of
endogenous ouabain. Chin J Pathophy. 14:9131998.In Chinese.
|
|
9
|
Dechend R, Viedt C, Müller DN, Ugele B,
Brandes RP, Wallukat G, Park JK, Janke J, Barta P, Theuer J, et al:
AT1 receptor agonistic antibodies from preeclamptic patients
stimulate NADPH oxidase. Circulation. 107:1632–1639. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vento-Tormo R, Rodríguez-Ubreva J, Lisio
LD, Islam AB, Urquiza JM, Hernando H, López-Bigas N, Shannon-Lowe
C, Martínez N, Montes-Moreno S, et al: NF-κB directly mediates
epigenetic deregulation of common microRNAs in Epstein-Barr
virus-mediated transformation of B-cells and in lymphomas. Nucleic
Acids Res. 42:11025–11039. 2014. View Article : Google Scholar :
|
|
11
|
Castri P, Lee YJ, Ponzio T, Maric D, Spatz
M, Bembry J and Hallenbeck J: Poly(ADP-ribose) polymerase-1 and its
cleavage products differentially modulate cellular protection
through NF-kappaB-dependent signaling. Biochim Biophys Acta.
1843:640–651. 2014. View Article : Google Scholar :
|
|
12
|
Hu WT, Huang LL, Li MQ, Jin LP, Li DJ and
Zhu XY: Decidual stromal cell-derived IL-33 contributes to Th2 bias
and inhibits decidual NK cell cytotoxicity through NF-κB signaling
in human early pregnancy. J Reprod Immunol. 109:52–65. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu LJ, Wang B, Parobchak N, Roche N and
Rosen T: STAT3 cooperates with the non-canonical NF-κB signaling to
regulate pro-labor genes in the human placenta. Placenta.
36:581–586. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yu Y, Wang L, Tang W, Zhang D and Shang T:
RNA interference-mediated knockdown of Notch-1 inhibits migration
and invasion, downregulates matrix metalloproteinases and
suppresses NF-κB signaling pathway in trophoblast cells. Acta
Histochem. 116:911–919. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Simsek Y, Gul M, Celik O, Aydin NE, Arda
Düz S, Celik E, Ozerol E, Özerol IH and Tanbek K: Nuclear
transcription factor-kappa beta-dependent ultrastructural
alterations within the placenta and systemic inflammatory
activation in pregnant patients with hemolysis, elevated liver
functions and low thrombocyte count (HELLP) syndrome: A
case-control study. Hypertens Pregnancy. 32:281–291. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang LL, Su S, Awale R, Zhang XY, Zhong
LL and Tang H: Expression of anti-inflammatory mediator lipoxin A4
and inflammation responsive transcriptive factors NF-kappa B in
patients with preeclampsia. Clin Exp Obstet Gynecol. 41:561–566.
2014.PubMed/NCBI
|
|
17
|
Xue P, Zheng M, Gong P, Lin C, Zhou J, Li
Y, Shen L, Diao Z, Yan G, Sun H, et al: Single administration of
ultra-low-dose lipopolysaccharide in rat early pregnancy induces
TLR4 activation in the placenta contributing to preeclampsia. PLoS
One. 10:e01240012015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Vaughan JE and Walsh SW: Activation of
NF-κB in placentas of women with preeclampsia. Hypertens Pregnancy.
31:243–251. 2012. View Article : Google Scholar
|
|
19
|
Craici IM, Wagner SJ, Weissgerber TL,
Grande JP and Garovic VD: Advances in the pathophysiology of
pre-eclampsia and related podocyte injury. Kidney Int. 86:275–285.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dai R, Phillips RA, Karpuzoglu E, Khan D
and Ahmed SA: Estrogen regulates transcription factors STAT-1 and
NF-kappaB to promote inducible nitric oxide synthase and
inflammatory responses. J Immunol. 183:6998–7005. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Qiu J: Proteomics analysis of effect of
endogeneous digitalis-like substance on human endothelial cells.
PhD Degree Thesis. Shandong University; 2007
|
|
22
|
Wu YJ, Zheng LL and Xin H: Changes and
clinical significance of Annexin A2 and its antibody in patients
with preeclampsia. Chin Gen Pract. 15:1575–1578. 2012.
|
|
23
|
Xie X and Gou WL: Obstetrics and
Gynecology. People's Medical Publishing House; Beijing: pp.
264–267. 2013
|
|
24
|
Dasgupta A, Kang E and Datta P: The new
enzyme-linked immunosorbent digoxin assay on the ADVIA Integrated
Modular System is virtually free from oleander interference. Ther
Drug Monit. 28:282–285. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Amitava D and Meredith AR: Ginseng and
digoxin assays. Discussion. Am J Clin Pathol. 124:229–236.
2005.
|
|
26
|
Reyes MA, Actor JK, Risin SA and Dasgupta
A: Effect of Chinese medicines Chan Su and Lu-Shen-Wan on serum
digoxin measurement by Digoxin III, a new digoxin immunoassay. Ther
Drug Monit. 30:95–99. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Benaitreau D, Dos Santos E, Leneveu MC, De
Mazancourt P, Pecquery R and Dieudonné MN: Adiponectin promotes
syncytialisation of BeWo cell line and primary trophoblast cells.
Reprod Biol Endocrinol. 8:1282010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Egger D and Bienz K: Protein (western)
blotting. Mol Biotechnol. 1:289–305. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bilano VL, Ota E, Ganchimeg T, Mori R and
Souza JP: Risk factors of pre-eclampsia/eclampsia and its adverse
outcomes in low- and middle-income countries: A WHO secondary
analysis. PLoS One. 9:e911982014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hund M, Allegranza D, Schoedl M, Dilba P,
Verhagen-Kamerbeek W and Stepan H: Multicenter prospective clinical
study to evaluate the prediction of short-term outcome in pregnant
women with suspected preeclampsia (PROGNOSIS): Study protocol. BMC
Pregnancy Childbirth. 14:3242014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ishkaraeva-Yakovleva VV, Fedorova OV,
Solodovnikova NG, Frolova EV, Bzhelyansky AM, Emelyanov IV, Adair
CD, Zazerskaya IE and Bagrov AY: DigiFab interacts with endogenous
cardiotonic steroids and reverses preeclampsia-induced Na/K-ATPase
inhibition. Reprod Sci. 19:1260–1267. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Blaustein MP and Hamlyn JM: Signaling
mechanisms that link salt retention to hypertension: Endogenous
ouabain, the Na(+) pump, the Na(+)/Ca(2+) exchanger and TRPC
proteins. Biochim Biophys Acta. 1802:1219–1229. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fedorova OV, Agalakova NI, Talan MI,
Lakatta EG and Bagrov AY: Brain ouabain stimulates peripheral
marinobufagenin via angiotensin II signalling in NaCl-loaded Dahl-S
rats. J Hypertens. 23:1515–1523. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ding YL, Yu L and Hu Y: Expression of
angiotensin II type 1 receptor and angiotensinogen in preeclamptic
placenta. Chin J Perina Med. 17:269–271. 2004.
|
|
35
|
Takahashi H: Upregulation of the
Renin-Angiotensin-aldosterone-ouabain system in the brain is the
core mechanism in the genesis of all types of hypertension. Int J
Hypertens. 2012:2427862012. View Article : Google Scholar
|
|
36
|
Xavier FE, Salaices M, Márquez-Rodas I,
Alonso MJ, Rossoni LV, Vassallo DV and Balfagón G: Neurogenic
nitric oxide release increases in mesenteric arteries from ouabain
hypertensive rats. J Hypertens. 22:949–957. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xavier FE, Rossoni LV, Alonso MJ, Balfagón
G, Vassallo DV and Salaices M: Ouabain-induced hypertension alters
the participation of endothelial factors in alpha-adrenergic
responses differently in rat resistance and conductance mesenteric
arteries. Br J Pharmacol. 143:215–225. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ramírez-Vélez R, Bustamante J,
Czerniczyniec A, Aguilar de Plata AC and Lores-Arnaiz S: Effect of
exercise training on eNOS expression, NO production and oxygen
metabolism in human placenta. PLoS One. 8:e802252013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Odibo AO, Zhong Y, Longtine M, Tuuli M,
Odibo L, Cahill AG, Macones GA and Nelson DM: First-trimester serum
analytes, biophysical tests and the association with pathological
morphometry in the placenta of pregnancies with preeclampsia and
fetal growth restriction. Placenta. 32:333–338. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Fernández Celadilla L, Carbajo Rueda M and
Muñoz Rodríguez M: Prolonged inhibition of nitric oxide synthesis
in pregnant rats: Effects on blood pressure, fetal growth and
litter size. Arch Gynecol Obstet. 271:243–248. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Var A, Yildirim Y, Onur E, Kuscu NK,
Uyanik BS, Goktalay K and Guvenc Y: Endothelial dysfunction in
preeclampsia. Increased homocysteine and decreased nitric oxide
levels. Gynecol Obstet Invest. 56:221–224. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Song H, Karashima E, Hamlyn JM and
Blaustein MP: Ouabain-digoxin antagonism in rat arteries and
neurones. J Physiol. 592:941–969. 2014. View Article : Google Scholar :
|
|
43
|
Gilbert JS, Ryan MJ, LaMarca BB, Sedeek M,
Murphy SR and Granger JP: Pathophysiology of hypertension during
preeclampsia: Linking placental ischemia with endothelial
dysfunction. Am J Physiol Heart Circ Physiol. 294:H541–H550. 2008.
View Article : Google Scholar
|
|
44
|
López-Jaramillo P, Arenas WD, García RG,
Rincon MY and López M: The role of the L-arginine-nitric oxide
pathway in preeclampsia. Ther Adv Cardiovasc Dis. 2:261–275. 2008.
View Article : Google Scholar
|
|
45
|
Pisaneschi S, Strigini FA, Sanchez AM,
Begliuomini S, Casarosa E, Ripoli A, Ghirri P, Boldrini A, Fink B,
Genazzani AR, et al: Compensatory fetoplacental upregulation of the
nitric oxide system during fetal growth restriction. PLoS One.
7:e452942012. View Article : Google Scholar
|
|
46
|
Sathishkumar K, Elkins R, Chinnathambi V,
Gao H, Hankins GD and Yallampalli C: Prenatal testosterone-induced
fetal growth restriction is associated with downregulation of rat
placental amino acid transport. Reprod Biol Endocrinol. 9:1102011.
View Article : Google Scholar
|
|
47
|
Johal T, Lees CC, Everett TR and Wilkinson
IB: The nitric oxide pathway and possible therapeutic options in
pre-eclampsia. Br J Clin Pharmacol. 78:244–257. 2014. View Article : Google Scholar :
|
|
48
|
Mangialardi G, Monopoli A, Ongini E,
Spinetti G, Fortunato O, Emanueli C and Madeddu P: Nitric
oxide-donating statin improves multiple functions of circulating
angiogenic cells. Br J Pharmacol. 164:570–583. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Maron BA, Oldham WM, Chan SY, Vargas SO,
Arons E, Zhang YY, Loscalzo J and Leopold JA: Upregulation of
steroidogenic acute regulatory protein by hypoxia stimulates
aldosterone synthesis in pulmonary artery endothelial cells to
promote pulmonary vascular fibrosis. Circulation. 130:168–179.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Jacobs BE, Liu Y, Pulina MV, Golovina VA
and Hamlyn JM: Normal pregnancy: Mechanisms underlying the paradox
of a ouabain-resistant state with elevated endogenous ouabain,
suppressed arterial sodium calcium exchange, and low blood
pressure. Am J Physiol Heart Circ Physiol. 302:H1317–H1329. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Saunders R and Scheiner-Bobis G: Ouabain
stimulates endothelin release and expression in human endothelial
cells without inhibiting the sodium pump. Eur J Biochem.
271:1054–1062. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Kaur G, Kapoor N, Mohan P, Sri Nageswari
K, Singh MJ and Prasad R: Alteration in ouabain-sensitive sodium
potassium pump of erythrocytes during pregnancy induced
hypertension: A kinetic study. J Biochem Mol Biol Biophys.
6:163–166. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Harvey KA, Xu Z, Pavlina TM, Zaloga GP and
Siddiqui RA: Modulation of endothelial cell integrity and
inflammatory activation by commercial lipid emulsions. Lipids
Health Dis. 14:92015. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Bharadwaj A, Bydoun M, Holloway R and
Waisman D: Annexin A2 heterotetramer: Structure and function. Int J
Mol Sci. 14:6259–6305. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Wu YH, Chiu DT, Lin HR, Tang HY, Cheng ML
and Ho HY: Glucose-6-phosphate dehydrogenase enhances antiviral
response through downregulation of NADPH sensor HSCARG and
upregulation of NF-κB signaling. Viruses. 7:6689–6706. 2015.
View Article : Google Scholar : PubMed/NCBI
|
